lapatinib has been researched along with interleukin-8 in 1 studies
Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
---|---|---|---|---|---|
1,919 | 305 | 1,442 | 23,523 | 1,167 | 9,990 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, S; Diab, AA; El Mahdy, MM; El-Husseiny, N; El-Sherif, AA; El-Shinawi, M; Mohamed, HT; Mohamed, MM; Safwat, G | 1 |
1 other study(ies) available for lapatinib and interleukin-8
Article | Year |
---|---|
IL-8 secreted by tumor associated macrophages contribute to lapatinib resistance in HER2-positive locally advanced breast cancer via activation of Src/STAT3/ERK1/2-mediated EGFR signaling.
Topics: Adult; Aged; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Interleukin-8; Lapatinib; MAP Kinase Signaling System; Mastectomy; Middle Aged; Receptor, ErbB-2; Signal Transduction; Tumor-Associated Macrophages | 2021 |